Governance Formycon AG

FYB

DE000A1EWVY8

Biotechnology & Medical Research

Market Closed - Xetra Other stock markets 16:35:27 13/02/2026 GMT			5-day change	1st Jan Change
23.80 ^EUR	+0.85%		+3.48%	-7.03%

02-11	Formycon, Lotus Sign License Deal for Keytruda Biosimilar in Asia-Pacific Region	MT
02-11	Swiss stocks - Factors to watch on February 11	RE

Executive Committee: Formycon AG

Manager

Positions heldSince

Stefan Glombitza

Chief Executive Officer

30/06/2022

Sabrina Müller

Investor Relations Contact	-
Public Communications Contact	-

Meike Heger

Human Resources Officer

Andreas Seidl

Chief Tech/Sci/R&D Officer

30/06/2022

Enno Spillner

57 year

Director of Finance/CFO

31/03/2023

Composition of the Board of Directors: Formycon AG

Director

CommitteesSince

Wolfgang Essler

54 year

Chairman

11/06/2024

Colin Michael Bond

66 year

Audit Committee Chair	31/10/2024
Compensation Committee	31/10/2024
Governance Committee	31/10/2024
Nominating Committee	31/10/2024

Klaus Röhrig

49 year

Audit Committee Chair	09/12/2020
Audit Committee	07/05/2023
Compensation Committee	07/05/2023
Nominating Committee	07/05/2023

Nicholas Haggar

60 year

Audit Committee

31/08/2023

Graham Dixon

65 year

Director/Board Member

17/06/2025

Bodo Coldewey

54 year

Director/Board Member

11/06/2024

Latest Appointments: Formycon AG

18/06/25	Formycon Ag Elects Graham Keith Dixon as A New Member of the Supervisory Board	CI
14/11/24	Formycon AG Appoints Colin Bond as Director	CI
01/07/22	Formycon AG Announces Supervisory Board and Executive Changes	CI
19/05/22	Formycon AG Announces Changes to Its Executive Board	CI
13/08/18	Formycon Appoints Thomas Siklosi to the Advisory Board	CI
16/11/17	Formycon AG Appoints Stefan Glombitza as COO	CI
01/02/16	Formycon AG Appoints Johannes Buchner to Advisory Board	CI

More news

Former Officers and Directors: Formycon AG

Insider

Positions held

SinceUntil

Olaf Stiller

Chairman	31/12/2006	11/06/2024
Founder	31/12/2006	11/06/2024

Peter Wendeln

Director/Board Member

11/06/2024

Thomas Strüngmann

Director/Board Member

29/06/2022

24/07/2023

Nicolas Combé

Director of Finance/CFO	31/07/2010	29/06/2022
Founder	31/12/2006	29/06/2022
Investor Relations Contact	31/07/2010	-
Public Communications Contact	31/07/2010	-

Carsten Brockmeyer

Chief Executive Officer

29/06/2022

Friedrich Wilhelm Steinweg

Chief Executive Officer	31/12/2006	-
Founder	31/12/2006	-

Christofer Radic

Investor Relations Contact

Bertrand Malmendier

Director/Board Member

Katrin Möws

Corporate Officer/Principal

Matthias Wittmar

Chief Tech/Sci/R&D Officer	10/09/2012	-
Corporate Officer/Principal	-	10/09/2012

Hermann Vogt

Director/Board Member

Aisha Chaudhry

Sales & Marketing

Thorsten Schüller

Investor Relations Contact	-	-
Public Communications Contact	-	-

Age distribution of managers

Parity Men Women

Male	10
Female	2

Of which Executive Committee

Male	3
Female	2

Of which Directors

Male	6
Female	0

Revisions

Révisions CA 1 an

Révisions CA 4 mois

Révisions CA 1 mois

Révisions BNA 1 an

Révisions BNA 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

Formycon AG is a Germany based Company. The Company is engaged in providing biosimilar drugs and formulations. The Company focuses on treatments in ophthalmology, immunology and other chronic diseases, covering all steps of biosimilar development process, from early-stage analysis of the originator drug to the preclinical and clinical testing phases, as well as the preparation of dossiers for marketing approval.

Employees

250

Sector

Biotechnology & Medical Research

Calendar

04-22 - Q4 2025 Earnings Release (Projected)

More about the company